These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2845711)

  • 1. Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology.
    Dilsaver SC
    Acta Psychiatr Scand; 1988 Jul; 78(1):1-7. PubMed ID: 2845711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena.
    Dilsaver SC
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(2):137-61. PubMed ID: 1968671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal phenomena associated with antidepressant and antipsychotic agents.
    Dilsaver SC
    Drug Saf; 1994 Feb; 10(2):103-14. PubMed ID: 7912078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F; Bouvy PF; Touw DJ
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic withdrawal symptoms: phenomenology and pathophysiology.
    Dilsaver SC; Alessi NE
    Acta Psychiatr Scand; 1988 Mar; 77(3):241-6. PubMed ID: 2899377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam.
    Naylor MW; Grunhaus L; Cameron O
    J Nerv Ment Dis; 1987 Feb; 175(2):111-4. PubMed ID: 3806075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranylcypromine discontinuation symptoms and withdrawal delirium.
    Freudenmann RW; Baumgarten E; Hawlik AE; Schönfeldt-Lecuona C; Gahr M
    J Clin Psychopharmacol; 2013 Aug; 33(4):574-6. PubMed ID: 23771195
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute psychosis following phenelzine discontinuation.
    Liskin B; Roose SP; Walsh BT; Jackson WK
    J Clin Psychopharmacol; 1985 Feb; 5(1):46-7. PubMed ID: 3973072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delirium, thrombocytopenia, insomnia, and mild liver damage associated with MAOI withdrawal.
    Bellon A; Coverdale JH
    Eur J Clin Pharmacol; 2009 Dec; 65(12):1269-70. PubMed ID: 19655131
    [No Abstract]   [Full Text] [Related]  

  • 10. Antidepressant withdrawal phenomena.
    Dilsaver SC; Greden JF
    Biol Psychiatry; 1984 Feb; 19(2):237-56. PubMed ID: 6324897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranylcypromine withdrawal phenomena.
    Halle MT; Dilsaver SC
    J Psychiatry Neurosci; 1993 Jan; 18(1):49-50. PubMed ID: 8461282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danger of MAOI therapy after fluoxetine withdrawal.
    Graham PM; Ilett KF
    Lancet; 1988 Nov; 2(8622):1255-6. PubMed ID: 2903989
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances.
    Sjöqvist F
    Proc R Soc Med; 1965 Nov; 58(11 Part 2):967-78. PubMed ID: 4952963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
    Guillem K; Vouillac C; Koob GF; Cador M; Stinus L
    Biol Psychiatry; 2008 Jan; 63(2):158-63. PubMed ID: 17643399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAOIs and depression treatment guidelines.
    Thase ME
    J Clin Psychiatry; 2012 Jul; 73(7):e24. PubMed ID: 22901357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems with switching rapidly from one MAOI to another.
    Jefferson JW
    J Clin Psychiatry; 1998 Feb; 59(2):87. PubMed ID: 9501898
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of monoamine oxidase inhibitor-associated insomnia with trazodone.
    Nierenberg AA; Keck PE
    J Clin Psychopharmacol; 1989 Feb; 9(1):42-5. PubMed ID: 2708555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant withdrawal symptoms-telephone calls to a national medication helpline.
    Taylor D; Stewart S; Connolly A
    J Affect Disord; 2006 Oct; 95(1-3):129-33. PubMed ID: 16797080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively.
    Chamberlain SR; Baldwin DS
    CNS Drugs; 2021 Jul; 35(7):703-716. PubMed ID: 34240393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report.
    Safferman AZ; Masiar SJ
    Ann Pharmacother; 1992 Mar; 26(3):337-8. PubMed ID: 1554951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.